Skip to main content
Log in

No indication for CALR mutation analysis in Irish patients presenting with deep vein thrombosis or pulmonary embolism

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Martin K (2017) Risk factors for and management of MPN-associated bleeding and thrombosis. Curr Hematol Malig Rep 12:389–396

    Article  Google Scholar 

  2. Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi ML (2016) Thrombotic risk correlates with mutational status in true essential thrombocythemia. Eur J Clin Investig 46:683–689

    Article  CAS  Google Scholar 

  3. Zerjavic K, Zagradisnik B, Stangler Herodez S, Lokar L, Glaser Krasevac M, Kokalj Vokac N (2010) Is the JAK2 V617F mutation a hallmark for different forms of thrombosis? Acta Haematol 124:49–56

    Article  CAS  Google Scholar 

  4. Ianotto JC, Chauveau A, Luque Paz D, Delluc A, Tromeur C, Couturier MA, Gouillou M, Berthou C, Mottier D, Ugo V (2016) Absence of CALR mutation among a cohort of 394 unselected patients with a first episode of unprovoked venous thromboembolism. Thromb Haemost 115:225–226

    Article  Google Scholar 

  5. Ianotto JC, Chauveau A, Mottier D, Ugo V, Berthou C, Lippert E, Delluc A (2017) JAK2 V617F and calreticulin mutations in recurrent venous thromboembolism: results from the EDITH prospective cohort. Ann Hematol 96:383–386

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen E. Langabeer.

Ethics declarations

This study was performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from participants at the referring centres.

Conflict of interest

The author declares that he has no conflicts of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Langabeer, S.E. No indication for CALR mutation analysis in Irish patients presenting with deep vein thrombosis or pulmonary embolism. Ir J Med Sci 188, 1459–1460 (2019). https://doi.org/10.1007/s11845-019-02018-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-019-02018-3

Navigation